Inventor · disambiguated record
Donmienne Doen Mun Leung
Also filed as: LEUNG DONMIENNE · LEUNG DONMIENNE DOEN MUN
13 granted patents·6 pending applications·51 citations·filing 2008–2024
89Inventor score
Top patents by PatentIndex Score
19 records- 0189US8183346B2Anti-ferroportin 1 monoclonal antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2009·Granted May 22, 2012·17 cites·7 claims
- 0289US7820163B2Anti-hepcidin antibodies and uses thereofLILLY CO ELI·Filed 2008·Granted Oct 26, 2010·11 cites·9 claims
- 0384US8609817B2Anti-hepcidin-25 selective antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2009·Granted Dec 17, 2013·9 cites·17 claims
- 0477US8679497B2Anti-ferroportin 1 monoclonal antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2012·Granted Mar 25, 2014·2 cites·20 claims
- 0576US9580499B2VEGFR2/Ang2 compoundsLILLY CO ELI·Filed 2015·Granted Feb 28, 2017·2 cites·10 claims
- 0675US9243046B2Variants of human GDNFLEUNG DONMIENNE DOEN MUN·Filed 2012·Granted Jan 26, 2016·2 cites·2 claims
- 0775US8765129B2Anti-hepcidin antibodies and uses thereofLILLY CO ELI·Filed 2012·Granted Jul 1, 2014·2 cites·5 claims
- 0874US8329174B2Anti-hepcidin antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2010·Granted Dec 11, 2012·2 cites·9 claims
- 0973US9416182B2Anti-TNF-anti-IL-17 bispecific antibodiesLILLY CO ELI·Filed 2014·Granted Aug 16, 2016·2 cites·6 claims
- 1073US2024398973A1Engineered antibody compounds and conjugates thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1167US9932397B2VEGFA/Ang2 CompoundsLILLY CO ELI·Filed 2016·Granted Apr 3, 2018·1 cites·16 claims
- 1263US9695241B2Ang2 antibodiesLILLY CO ELI·Filed 2015·Granted Jul 4, 2017·1 cites·13 claims
- 1362US12227538B2Glucocorticoid receptor agonistsLILLY CO ELI·Filed 2022·Granted Feb 18, 2025·0 cites·23 claims
- 1458US2023192837A1Human tumor necrosis factor alpha antibodiesLILLY CO ELI·Filed 2022·Application pending·0 cites
- 1557US2024082414A1Human tumor necrosis factor alpha antibody glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 1656US2024100176A1Human interleukin-4 receptor alpha antibody glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 1756US2020155702A1Engineered Antibody Compounds and Conjuates ThereofLILLY CO ELI·Filed 2018·Application pending·0 cites
- 1854US11891441B2Human interleukin-4 receptor alpha antibodiesLILLY CO ELI·Filed 2022·Granted Feb 6, 2024·0 cites·69 claims
- 1945US2017121411A1VEGFR2/Ang2 CompoundsLILLY CO ELI·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →